Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Scientific Session

Rheumatoid arthritis (RA)

13M127: Hench Memorial Lecture

Monday, November 13, 2023
12:00 PM – 1:00 PM PT
Location: Room 11A-B
CE: 1

In Person On Demand

    Speaker(s)

  • Jane Buckner, MD

    Benaroya Research Institute at Virginia Mason
    Seattle, WA, United States

    Disclosure(s): Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Gentibio: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Intellectual Property/Patents (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); hotspot therapeutics: Consultant (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Omeros: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)

Antigen specific therapies allow manipulation of the immune response in a manner that targets the pathogenic processes and affected organs in autoimmunity while sparing the remainder of the immune response. Multiple approaches are being developed to target specific antigens in hope to achieve the goal of tolerance in autoimmunity. In this lecture I will the disease settings where antigen specific therapy may be most useful, the challenges that remain to develop such therapies and prospect for the future.

Learning Objectives:

  • Understand why antigen targeted treatments in some autoimmune diseases may be useful
  • Identify the challenges and limitations of antigen specific therapies
  • Understand the therapeutic approaches being developed to delivering antigen specific therapy

Presentations:

  • 12:00 PM – 12:45 PM PT
    Antigen Specific Therapy: Is It the Holy Grail for Autoimmunity?

    Speaker: Jane H. Buckner, MD – Benaroya Research Institute at Virginia Mason

  • 12:45 PM – 1:00 PM PT
    Q&A